Attack

BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment

Retrieved on: 
Friday, February 23, 2024
Incidence, AAAAI, Pharmacy, Attack, Expert network, Tranexamic acid, Prior, Effectiveness, Pharmacist, Washington Convention Center, University, Conditional sentence, Day, Lanadelumab, Safety, Androgen, HAE, History, Hereditary angioedema, Tolerability, Monitoring, Internal medicine, Walter, BioCryst Pharmaceuticals, Medicine, Disease, Ageing, Observational study, Poster, American Academy, Pharmaceutical industry

“These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.

Key Points: 
  • “These additional analyses of real-world use of ORLADEYO show that any person living with HAE has the potential to experience a rapid, substantial and sustained reduction in their monthly attack rate with ORLADEYO.
  • These analyses present the overall attack rate progression and attack rate progression stratified by severity (i.e., number of attacks at baseline), prior prophylaxis and C1-INH level and function.
  • These findings further demonstrate that ORLADEYO can help maintain disease control in patients with lower baseline attack rates and further reduce attack rates in patients with more active disease.
  • Berotralstat Prophylaxis Reduces HAE Attack Rates Regardless of Baseline Attacks: Real-World Outcomes; Poster #012; Friday, February 23, 3:15-4:15 p.m.

Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting

Retrieved on: 
Thursday, February 22, 2024
Bradykinin receptor B2, AAAAI, ODT, Hereditary angioedema, Attack, Safety, Washington Convention Center, EST, Reason (argument), Angioedema, HAE, Death, Abstract, Journal, Walter, Asthma, Science, Patient satisfaction, American Academy, Pharmaceutical industry

CHAPTER-1 is a two-part, Phase 2 study evaluating the efficacy, safety, and tolerability of deucrictibant for long-term prophylaxis against angioedema attacks in HAE type 1 and type 2 (HAE-1/2).

Key Points: 
  • CHAPTER-1 is a two-part, Phase 2 study evaluating the efficacy, safety, and tolerability of deucrictibant for long-term prophylaxis against angioedema attacks in HAE type 1 and type 2 (HAE-1/2).
  • 34 participants were treated with double-blinded study drug (placebo or deucrictibant, 20 or 40 mg/day) for 12 weeks of treatment.
  • “These data validate the mechanism of deucrictibant to provide early and sustained protection from HAE attacks.
  • By better understanding and addressing these factors, we aspire to make our commitment to ‘pioneering science for patient choice’ a reality.”

Cloudflare Firewall for AI Will Help Secure AI Applications, At Scale and For Free

Retrieved on: 
Monday, March 4, 2024
Apps, Applications, Technology, Mobile, Wireless, Security, Software, Networks, Internet, Data Management, Artificial Intelligence, Weapon, AI, Attack, Language, Firewall, LLM, Organization, Abuse, Medical device

A recent study revealed that only one in four C-suite level executives have the confidence that their organizations are well-prepared to address AI risks.

Key Points: 
  • A recent study revealed that only one in four C-suite level executives have the confidence that their organizations are well-prepared to address AI risks.
  • “With Cloudflare’s Firewall for AI, we are helping build security into the AI landscape from the start.
  • Cloudflare will help enable customers to:
    Rapidly detect new threats: Firewall for AI may be deployed in front of any LLM running on Cloudflare’s Workers AI.
  • Cloudflare Firewall for AI will add additional layers to its existing comprehensive security platform , ultimately plugging the threats posed by emerging technology.

Sysdig Celebrates Falco Graduation Within Cloud Native Computing Foundation

Retrieved on: 
Thursday, February 29, 2024
Software, Technology, Data Management, Security, Cloud, Computation, Materiality, Skyscanner, Agility, Attack, IBM, Growth, EBPF, Documentation, CNCF, Organization, Okta, Apple, GitLab, Security engineering, Red Hat, Environment, Risk management

Sysdig, the leader in cloud security powered by runtime insights, today celebrates Falco becoming a graduated project within the Cloud Native Computing Foundation (CNCF).

Key Points: 
  • Sysdig, the leader in cloud security powered by runtime insights, today celebrates Falco becoming a graduated project within the Cloud Native Computing Foundation (CNCF).
  • Companies publicly building on Falco include Shopify, GitLab, Skyscanner, Frame.io, and Booz Allen Hamilton; project maintainers include developers from Sysdig, IBM, Apple, and Red Hat.
  • The future of security is open: This belief motivated the team at Sysdig to contribute Falco to the CNCF in 2018.
  • By using Falco, we knew we were adopting a standard for cloud and container runtime security.

KalVista Pharmaceuticals Presents Additional Phase 3 KONFIDENT Data at the 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting

Retrieved on: 
Monday, February 26, 2024
Science, Other Science, Biotechnology, Research, Pharmaceutical, Health, Clinical Trials, Other Health, Division, AAAAI, MD, Attack, Annual general meeting, Safety, University, HAE, Hereditary angioedema, KALV, American Academy, Pharmaceutical industry

Additional safety analyses demonstrated that the safety profiles associated with one dose or two doses of sebetralstat 300 mg or 600 mg were comparable to placebo.

Key Points: 
  • Additional safety analyses demonstrated that the safety profiles associated with one dose or two doses of sebetralstat 300 mg or 600 mg were comparable to placebo.
  • Data presented as a supplement also showed that the median time to all endpoints was shorter for attacks with higher initial severity, at both dose levels.
  • “If approved, we believe that a single dose of sebetralstat 300 mg would appear to be appropriate for most HAE attacks.
  • “We believe that these additional efficacy and safety data only strengthen the case for sebetralstat to become the first, oral on-demand treatment available to the HAE community.”

Cofense Annual Report Indicates 105% Increase in Malicious Emails Bypassing Secure Email Gateways

Retrieved on: 
Tuesday, February 20, 2024
Data Management, Security, Technology, Software, Networks, Internet, Attack, Email spoofing, Risk, AMP, Form, Health care, SAT, Organization, Accelerated Mobile Pages, Statistics, PDR, Risk management

In just two years, Cofense PDR identified over 1.5 million malicious emails bypassing their customers’ Secure Email Gateways (SEGs), signaling a 37% increase in threats compared to 2022, and a staggering 310% increase over 2021.

Key Points: 
  • In just two years, Cofense PDR identified over 1.5 million malicious emails bypassing their customers’ Secure Email Gateways (SEGs), signaling a 37% increase in threats compared to 2022, and a staggering 310% increase over 2021.
  • To put this in context, the report highlights that Cofense detected at least one malicious email bypassing their customers’ SEGs every 57 seconds.
  • The Cofense Annual Report points out that secure email gateways struggle to keep pace with sophisticated phishing campaigns and relying on 'good enough' email security is no longer an option for most enterprises.
  • Secure email gateways are struggling to keep pace with the rapidly evolving nature of phishing campaigns, evidenced by a concerning 104.5% increase in the number of malicious emails bypassing SEGs in 2024.

HiddenLayer AI Threat Landscape Report Finds That 77% of Companies Identified Breaches to Their AI in the Past Year

Retrieved on: 
Wednesday, March 6, 2024
Algorithm, Privacy, Artificial intelligence, AI, Attack, Incident, Artifact, AIS, Data science, Evaluation, Entrepreneurship, Continuous monitoring, Risk, Computer security, Safety, Organization, MLOps, Anomaly, Research, Political lists, Medical device

AUSTIN, Texas, March 6, 2024 /PRNewswire/ -- HiddenLayer, the leading security provider for artificial intelligence (AI) models and assets, today released its inaugural AI Threat Landscape Report highlighting the pervasive use of AI and the risks involved in its deployment. Nearly all surveyed companies, 98%, consider at least some of their AI models crucial to their business success, and 77% identified breaches to their AI in the past year. Yet only 14% of IT leaders said their respective companies are planning and testing for adversarial attacks on AI models.

Key Points: 
  • Nearly all surveyed companies, 98%, consider at least some of their AI models crucial to their business success, and 77% identified breaches to their AI in the past year.
  • Yet only 14% of IT leaders said their respective companies are planning and testing for adversarial attacks on AI models.
  • The survey uncovered AI's widespread utilization by today's businesses as companies have, on average, a staggering 1,689 AI models in production.
  • In response, security for AI has become a priority, with 94% of IT leaders allocating budgets to secure their AI in 2024.

DDoS Attacks on Financial Services Industry Up 154%, According to New FS-ISAC/Akamai Report

Retrieved on: 
Wednesday, March 6, 2024
Attack, Critical, Growth, Data-rate units, Smoke, Hacktivism, MPPs, AKAM, Organization, Denial-of-service attack, Research, Insurance, Hygiene, Arms industry

RESTON, Va. and CAMBRIDGE, Mass., March 6, 2024 /PRNewswire/ -- FS-ISAC, the member-driven, not-for-profit organization that advances cybersecurity and resilience in the global financial system, and Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today released new research on the surge of distributed denial-of-service (DDoS) attacks threatening the financial services sector and its customers.

Key Points: 
  • The report, DDoS: Here to Stay , revealed that more than one-third (35%) of all DDoS attacks in 2023 were aimed at the financial services industry, which has surpassed the gaming sector as the most-attacked vertical.
  • Driven by a dramatic surge in the power of botnets and hacktivism motivated by the Russia-Ukraine War, the financial services industry experienced a 154% increase in DDoS attacks between 2022 to 2023.
  • Hacktivists and DDoS attacks can disrupt business operations, leading to a loss of credibility, customer trust, and financial damage.
  • In APAC, financial services ranked as the third-most attacked sector, representing 11% of DDoS attacks.

IBM Debuts New, State-of-the-Art Washington DC Cyber Response Training Facility

Retrieved on: 
Wednesday, March 6, 2024
Data breach, AI, Intelligence, Attack, IBM, Computer security, X-Force, Exercise, Government, Communication, Lead, IBM Consulting, Organization, Mind, EO, Environment, Face, Risk management

WASHINGTON, March 6, 2024 /PRNewswire/ -- IBM (NYSE: IBM) today announced the official opening of the new IBM X-Force Cyber Range in Washington, DC. The range includes new custom training exercises specifically designed to help U.S. federal agencies, their suppliers and critical infrastructure organizations more effectively respond to persistent and disruptive cyberattacks, and threats posed by AI. The state-of-the-art facility is designed to help everyone from legal and mission-critical leaders, to the C-Suite and technical security leaders prepare for a real-world cyber incident.

Key Points: 
  • WASHINGTON, March 6, 2024 /PRNewswire/ -- IBM (NYSE: IBM ) today announced the official opening of the new IBM X-Force Cyber Range in Washington, DC.
  • Building on nearly a decade of experience operating cyber response training facilities globally, IBM facilitators at the DC range guide participants through full-scale breach scenarios – ranging from AI code poisoning and destructive attacks to deepfake and zero-day attacks.
  • In addition to government agencies and critical infrastructure providers, businesses across all sectors can participate in cyber response training.
  • Learn more about the IBM X-Force Cyber Range in Washington, DC.

Pioneer in Cyber Insurance in Brazil Receives $1.5 Million Funding

Retrieved on: 
Tuesday, March 5, 2024
Acquisition, General Data Protection Regulation, MDR, Attack, Risk management, VCS, GDPR, Risk, SME, GWP, Insurance

SÃO PAULO, March 5, 2024 /PRNewswire/ -- Bluecyber.insure, a pioneering insurtech in cyber insurance in Brazil, has received a $1.5 million investment from VCs Invisto.com.vc and Bossa Invest, as well as strategic investors from the insurance market. "This investment reflects the investors' confidence in Bluecyber's mission to simplify and expand insurance coverage for digital life protection of SMEs and families throughout Latin America, an underserved market with an estimated gross written premium (GWP) of USD 17.3 billion," says Eduardo Rocha, CEO of Bluecyber.

Key Points: 
  • Bluecyber, which offers digital protection insurance to SMEs and families, will expand its operations in Latin America
    SÃO PAULO, March 5, 2024 /PRNewswire/ -- Bluecyber.insure, a pioneering insurtech in cyber insurance in Brazil, has received a $1.5 million investment from VCs Invisto.com.vc and Bossa Invest, as well as strategic investors from the insurance market.
  • "This investment reflects the investors' confidence in Bluecyber's mission to simplify and expand insurance coverage for digital life protection of SMEs and families throughout Latin America, an underserved market with an estimated gross written premium (GWP) of USD 17.3 billion," says Eduardo Rocha, CEO of Bluecyber.
  • The investment has already enabled the acquisition of Ismac.io, which developed an innovative Managed Detection and Response (MDR) platform.
  • "We are confident that this new phase will be a watershed in the cyber insurance industry, offering innovative and comprehensive solutions," says Bluecyber's co-founder Claudio Macedo.